Primary and stem cells are becoming important sources for the generation of organotypic tissue models used in many biopharmaceutical applications, regenerative medicine, disease modelling and drug discovery. During TEDD Annual Meeting 2019, we will discuss how stem cells have already been used in the drug discovery process and how novel technologies can be applied to attain widespread adoption of stem cell technology by the pharmaceutical and biotech industry. Several companies will exhibit during our famously long lunch break at the Greenhouse.

Call for Exhibition: follow the link below for more details. Space is limited.

TERMIS-EU 2019 meeting to be held from the 27.-31. May 2019. The theme of the meeting is ‘Tissue Engineering Therapies: From concept to clinical translation and commercialisation’. The meeting is highly important to scientists, clinicians and industries interested in tissue engineering and regenerative medicine therapies that aspire to revolutionise healthcare with their reparative capacity.

UPM provides animal free, bio-friendly hydrogels and other biomedical solutions extracted from birch wood. GrowDex® is ready to use, room temperature stable hydrogel that mimics the extracellular matrix (ECM), supporting cell growth and differentiation with consistent results.

The grant is awarded for excellent innovative research focussing on the investigation and therapy of human diseases. Projects are supported that significantly contribute to medical progress by employing animal-free, human-based approaches. The funding amounts to € 20.000. Researchers from Germany and the German-speaking area are invited to submit their applications in German or English.
Please send your application to zietek@aerzte-gegen-tierversuche.de. The application deadline is May 31st 2019.